313 related articles for article (PubMed ID: 16076502)
1. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory efficacy of cyclosal-nucleoside monophosphates of aciclovir and brivudin on DNA synthesis of orthopoxvi ruses.
Sauerbrei A; Meier C; Meerbach A; Wutzler P
Antivir Chem Chemother; 2006; 17(1):25-31. PubMed ID: 16542003
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV.
Meerbach A; Klöcking R; Meier C; Lomp A; Helbig B; Wutzler P
Antiviral Res; 2000 Jan; 45(1):69-77. PubMed ID: 10774591
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
Balzarini J; Haller-Meier F; De Clercq E; Meier C
Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
[TBL] [Abstract][Full Text] [Related]
6. Chemistry and anti-herpes simplex virus type 1 evaluation of cycloSal-nucleotides of acyclic nucleoside analogues.
Meier C; Habel L; Haller-Meier F; Lomp A; Herderich M; Klöcking R; Meerbach A; Wutzler P
Antivir Chem Chemother; 1998 Sep; 9(5):389-402. PubMed ID: 9875392
[TBL] [Abstract][Full Text] [Related]
7. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
8. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
9. A pyrimidine-pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity.
Fan X; Zhang X; Zhou L; Keith KA; Kern ER; Torrence PF
Bioorg Med Chem Lett; 2006 Jun; 16(12):3224-8. PubMed ID: 16603351
[TBL] [Abstract][Full Text] [Related]
10. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study.
Williams DL; Fitzmaurice T; Lay L; Forster K; Hefford J; Budge C; Blackmore K; Robinson JC; Field HF
Curr Eye Res; 2004; 29(2-3):215-8. PubMed ID: 15512970
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents.
Pirrung MC; Pansare SV; Sarma KD; Keith KA; Kern ER
J Med Chem; 2005 Apr; 48(8):3045-50. PubMed ID: 15828843
[TBL] [Abstract][Full Text] [Related]
13. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
Hussein IT; Menashy RV; Field HJ
Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
[TBL] [Abstract][Full Text] [Related]
14. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
[TBL] [Abstract][Full Text] [Related]
15. The 4',4'-difluoro analog of 5'-noraristeromycin: a new structural prototype for possible antiviral drug development toward orthopoxvirus and cytomegalovirus.
Roy A; Schneller SW; Keith KA; Hartline CB; Kern ER
Bioorg Med Chem; 2005 Jul; 13(14):4443-9. PubMed ID: 15908221
[TBL] [Abstract][Full Text] [Related]
16. cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
Meier C; Knispel T; Marquez VE; Siddiqui MA; De Clercq E; Balzarini J
J Med Chem; 1999 May; 42(9):1615-24. PubMed ID: 10229630
[TBL] [Abstract][Full Text] [Related]
17. FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture.
Reis SA; Moussatché N; Damaso CR
J Appl Microbiol; 2006 Jun; 100(6):1373-80. PubMed ID: 16696686
[TBL] [Abstract][Full Text] [Related]
18. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
Meier C; Knispel T; De Clercq E; Balzarini J
J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and antiherpes activity of acyclovir phosphoesters].
Galegov GA; Shobukhov VM; Leont'eva NA; Ias'ko MV
Bioorg Khim; 1997 Nov; 23(11):906-9. PubMed ID: 9518431
[TBL] [Abstract][Full Text] [Related]
20. Cell metabolism of acyclovir phosphonate derivatives and antiherpesvirus activity of their combinations with alpha2-interferon.
Skoblov YS; Karpenko IL; Jasko MV; Kukhanova MK; Andronova VL; Galegov GA; Sidorov GV; Myasoedov NF
Chem Biol Drug Des; 2007 Jun; 69(6):429-34. PubMed ID: 17581237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
